Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Otsuka Holdings Co., Ltd.    4578   JP3188220002

OTSUKA HOLDINGS CO., LTD.

(4578)
  Report
End-of-day quote. End-of-day quote Tokyo Stock Exchange - 03/24
3584 JPY   +4.22%
03/27OTSUKA : appoints Board Members and Audit & Supervisory Board Members (192KB)
PU
03/12OTSUKA : Chemical Announces Personnel Changes
AQ
03/11OTSUKA : Chemical Announces Personnel Changes (187KB)
PU
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Otsuka : Announcement of Changes in Company Officers at Otsuka Pharmaceutical Co., Ltd. (125KB)

share with twitter share with LinkedIn share with facebook
share via e-mail
12/11/2019 | 04:21am EDT

For Immediate Release

December 11, 2019

Company name

Otsuka Holdings Co., Ltd.

Representative

Tatsuo Higuchi

President and Representative Director, CEO

Code number

4578 First Section, Tokyo Stock Exchange

Inquiries

Yuji Kogure

Director, Investor Relations Department

Announcement of Changes in Company Officers at Otsuka Pharmaceutical Co., Ltd.

Otsuka Holdings Co., Ltd. and its subsidiary Otsuka Pharmaceutical Co., Ltd. announce that the changes described below have been made to the composition of company officers at Otsuka Pharmaceutical, pursuant to decisions by the boards of directors at Otsuka Holdings and at Otsuka Pharmaceutical on December 11 and December 9, respectively.

The change of company officers will be decided formally at the general shareholders meeting of Otsuka Pharmaceutical on March 10, 2020, and the subsequent board meeting.

Particulars

Details on role changes

Name

:

Tatsuo Higuchi

New title

:

Chairman, Otsuka Pharmaceutical Co., Ltd.

Effective date

March 10, 2020

Current title

President and Representative Director, Otsuka Pharmaceutical Co., Ltd.

Name

Makoto Inoue

New title

President and Representative Director, Otsuka Pharmaceutical Co., Ltd.

Effective date

March 10, 2020

Current title

Executive Deputy President, Otsuka Pharmaceutical Co., Ltd.

Tatsuo Higuchi serves concurrently as president and representative director, CEO of Otsuka Holdings

-1-

Disclaimer

Otsuka Holdings Co. Ltd. published this content on 11 December 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 December 2019 08:20:06 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on OTSUKA HOLDINGS CO., LTD.
03/27OTSUKA : appoints Board Members and Audit & Supervisory Board Members (192KB)
PU
03/12OTSUKA : Chemical Announces Personnel Changes
AQ
03/11OTSUKA : Chemical Announces Personnel Changes (187KB)
PU
02/17OTSUKA : Announces Personnel Changes
AQ
02/14OTSUKA : Announces Personnel Changes (193KB)
PU
02/14OTSUKA : announces FY2019 financial results
PU
02/14OTSUKA HOLDINGS CO., LTD. : Slide show results
CO
02/14OTSUKA HOLDINGS CO., LTD. : Annual results
CO
02/14OTSUKA HOLDINGS CO., LTD. : Nomination
CO
02/11OTSUKA HOLDINGS CO., LTD. : annual earnings release
More news
Financials (JPY)
Sales 2019 1 401 B
EBIT 2019 178 B
Net income 2019 129 B
Finance 2019 136 B
Yield 2019 2,47%
P/E ratio 2019 17,3x
P/E ratio 2020 14,8x
EV / Sales2019 1,50x
EV / Sales2020 1,38x
Capitalization 2 231 B
Chart OTSUKA HOLDINGS CO., LTD.
Duration : Period :
Otsuka Holdings Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OTSUKA HOLDINGS CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 5 008,33  JPY
Last Close Price 4 115,00  JPY
Spread / Highest target 45,8%
Spread / Average Target 21,7%
Spread / Lowest Target 2,07%
EPS Revisions
Managers
NameTitle
Tatsuo Higuchi President, CEO & Representative Director
Ichiro Otsuka Chairman
Yuko Makino Chief Financial Officer & Director
Atsumasa Makise Director
Sadanobu Tobe Director
Sector and Competitors